READ MOREArticles8th May 2019Aryaka Raises $50M to Accelerate Global Managed SD-WAN ExpansionSeries F, Led by Goldman Sachs, Enables Company to Quickly Grow Revenues, Headcount & Global Footprint Aryaka®, the global leader in managed SD-WAN, today announced it has closed a $50 million Series F round of funding led by Goldman Sachs Private Capital Investing. This brings Aryaka’s total funding to $184 million. Additionally, it was announced […]
READ MOREArticles6th August 20214 Smart Investments You Can Make in CollegeEarly investing is an opportunity to set yourself up for greater wealth over the long-term. And you don’t need to wait until you get a career to do it. There are ways that college students can invest now, and some of them require very little input. People think of investing for things like retirement, but investments can fund other things as well. You could leverage investment income to travel, pay off debts, send your kids to college, and so much more. While some investments should be set aside for retirement, others can be used to enjoy life with.
READ MOREArticles20th January 2025How to Successfully Navigate Unexpected ExpensesUnexpected expenses—those unplanned costs that unsettle our financial stability—invariably surface at the most inopportune times, compelling us to reallocate funds earmarked for other priorities. They differ from routine expenditures like rent or groceries by arising from emergencies or unforeseen events, rendering them challenging both to anticipate and mitigate. Unexpected expenses vary widely, from minor inconveniences, […]
READ MOREArticles17th September 2014Hong Kong Entrepreneur Buys 30 RollsIn what is believed to be the single biggest order for Rolls-Royce cars, flamboyant Chinese businessman Stephen Hung has just ordered 30 for a total of £20m.
READ MOREArticles26th October 2016Evotec Announces Its Intent to Acquire Cyprotex PlcAcquisition would add world-leading high-quality ADME-Tox services and strengthen Evotec's leadership in drug discovery
- Evotec will pay approximately £ 55.36 m (EUR 62.00 m) in cash for the full share capital of Cyprotex and funding of all existing debt of the AIM-listed company